Summary
In nine patients with ischemic heart disease the authors investigated the arterio-coronary venous difference of free amino acids in serum at rest and during pacing. At rest aspartate was the only amino acid with a marked positive arterio-coronary venous difference. At the peak of pacing, in addition to aspartate, there is a significant positive arterio-coronary venous difference in glutamate, leucine and isoleucine and a significantly negative difference in cystine-cysteine and glutamine with asparagine. When expressed in per cent of the arterial level, the negative difference in alanine is also significant. Among the mutual correlations of arterio-coronary venous differences the negative correlation between alanine and lactate is most significant, which suggests that under normal conditions pyruvate is transformed rather to alanine, while in ischemia lactate is formed from pyruvate, and released from the heart muscle. There is also a positive correlation between alanine and glutamine and between leucine, isoleucine and glutamate.
On the other hand, cystine-cysteine correlates very significantly but inversely with leucine, isoleucine and glutamate.
The arterio-coronary venous difference of aspartate, though significantly positive, does not correlate with any other amino acid. The arterio-coronary vernous differences of ammonia and uric acid correlate inversely, whereby uric acid, contrary to ammonia, is practically not released from the heart muscle.
Zusammenfassung
Die Autoren untersuchten bei 9 Patienten mit ischämischen Herzleiden die arterio-koronarvenöse Differenz von freien Fettsäuren im Serum unter Ruhebedingungen und während künstlichem Schrittmacherantrieb. Bei körperlicher Ruhe war Aspartat die einzige Aminosäure mit einer ausgesprochenen positiven arterio-koronarvenösen Differenz. Auf dem Höhepunkt des Schrittmacherantriebs war zusätzlich zum Aspartat eine positive arteriovenöse Differenz für Glutamat, Leucin und Isoleucin und eine signifikant negative Differenz für Cystin-Cystein und Glutamin zusammen mit Asparagin zu verzeichnen. Ausgedrückt als Prozentsatz des arteriellen Spiegels war die negative Differenz auch bei Alanin signifikant. Bei wechselseitiger Korrelation der arteriovenösen Differenzen war die negative Beziehung zwischen Alanin und Lactat am eindeutigsten, was dafür spricht, daß unter normalen Bedingungen Pyruvat eher zu Alanin umgeformt wird, während im Zustand der Ischämie Lactat aus Pyruvat gebildet und vom Herzmuskel freigesetzt wird. Auch ergibt sich eine positive Korrelation zwischen Alanin und Glutamat und zwischen Leucin, Isoleucin und Glutamat. Andererseits korreliert Cystin-Cystein hoch signifikant, aber invers mit Leucin, Isoleucin und Glutamat.
Die arterio-koronarvenöse Differenz von Aspartat, obwohl signifikant positiv, korreliert nicht mit irgendeiner anderen Aminosäure. Die arteriovenösen Differenzen von Ammoniak und Harnsäure korrelieren invers, wobei Harnsäure im Gegensatz zu Ammoniak praktisch nicht aus dem Herzmuskel freigesetzt wird.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berne, R. M., R. Rubio: Adenine nucleotide metabolism in the heart. Circulat. Res.35, Suppl. III, 109–120 (1974).
Böttger, I., G. R. Faloona, R. H. Unger: The effect of intensive physical exercise on pancreatic glucagon secretion. Diabetes20, abstract p. 339 (1971).
Brodan, V., J. Fabián, J. Pechar, D. Grafnetter: Myocardial metabolism during pacing in patients with significant stenotic atherosclerosis of coronary arteries (in Czech). Čas. Lék. čes.114, 1415–1419 (1975).
Brodan, V., J. Fabián, J. Pechar, D. Tomková: The metabolism of ammonia in the ischaemic myocardium at rest and during pacing (in Czech). Čas. Lék. čes.114, 31–32 (1975).
Brodan, V., E. Kuhn, J. Pechar, Z. Placer, Z. Slabochová: Influence of sodium glutamate on metabolism during physical exercise. Nutr. Rep. Intern.9, 223–232 (1974).
Brodanová, M., V. Brodan, M. Anděl, J. Pechar, D. Tomková: The influence of tolbutamide and glucagon on free plasma amino acids in cirrhotics. Proceedings of the Czechoslovak Physiological Society, Prague, February 1–3 (1977).
Buse, M. G., S. S. Reid: Leucine: a possible regulator of protein metabolism in muscle. Clin. Res.23, 412 A (1975).
Cahill, G. F. Jr.: Protein and amino acid metabolism in man. Circulat. Res.38, Suppl.I, 109–114 (1976).
Carlsten, A., B. Hallgren, R. Jagenburg, A. Svanborg, L. Werkö: Myocardial metabolism of glucose, lactic acid, amino acids, and fatty acids in healthy individuals at rest and at different work loads. Scand. J. clin. Invest.13, 418–428 (1964).
Dole, V. P.: Relationship between non esterified fatty acid and metabolism of glucose. J. clin. Invest.35, 150–154 (1956).
Fabián, J., V. Brodan, A. Belán: Pacing test in patients with ischaemic heart disease. Clinical, hemodynamic and metabolical picture of acute induced myocardial ischaemia. Rev. Czech. Med.22, 10–22 (1976).
Felig, P.: The glucose-alanine cycle. Metab. Clin. Exp.22, 179–207 (1973).
Felig, P., E. Pozefsky, E. Marliss, G. F. Cahill: Alanine: key role in gluconeogenesis. Science (Wash. D.C.)167, 1003–1004 (1970).
Felig, P., J. Wahren: Amino acid metabolism in exercising man. J. Clin. Invest.50, 2703–2714 (1971).
Gailis, L., E. Benmouyal: Endogenous alanine, glutamate, aspartate and glutamine in the perfused guinea-pig heart: Effects of substrates and cardioactive agents. Can. J. Biochem.51, 11–20 (1973).
Gudbjarnason, S.: Use of glycolytic metabolism in the assessment of hypoxia in human hearts. Cardiology57, 35–46 (1972).
Himms-Hagen, J.: Adrenergic receptors for metabolic responses in adipose tissue. Fed. Proc.29, 1388–1401 (1970).
Himwich, H. E., W. Goldfarb, L. H. Nahum: Changes of carbohydrate metabolism of the heart following coronary occlusion. Amer. J. Physiol.109, 403 (1934).
Hořejší, J., B. Slavík: Basic biochemical investigation in medicine (in Czech), SZdN, Prague (1953).
Kato, T.: Myocardial amino-nitrogen metabolism with special reference to ammonia metabolism. Jap. Circ. J.32, 1401–1416 (1968).
Kübler, W.: Myocardial energy metabolism in patients with ischemic heart disease. Basic Res. Cardiol.69, 105–112 (1974).
Lowenstein, J. M.: Ammonia production in the muscle and in other tissues: Purine nucleotide cycle. Physiol. Rev.52, 382–414 (1972).
Marliss, E. B., T. T. Aoki, T. Pozefsky, A. S. Most, G. F. Cahill: Muscle and splanchnic glutamine and glutamate metabolism in postabsorptive and starved man. J. Clin. Invest.50, 814–817 (1971).
Mudge, G. H., R. M. Mills, H. Taegtmeyer, R. Gorlin, M. Lesch: Alterations of myocardial amino acid metabolism in chronic ischemic heart disease. J. clin. Invest.15, 1185–1192 (1976).
Opie, L. H.: Metabolism of the heart in health and disease. Part I. Amer. Heart J.76, 685–698 (1968).
Owen, T. G., P. W. Hochachka: Purification and properties of dolphin muscle aspartate and alanine transaminases and their possible roles in the energy metabolism of diving mammals. Biochem. J.143, 541–553 (1974).
Pozefsky, T., P. Felig, J. D. Tobin, J. S. Soeldner, G. F. Cahill: Amino acid balance across tissues of the forearm in postabsorptive man. J. Clin. Invest.48, 2273–2282 (1969).
Ronca-Testoni, S., A. Raggi, C. Ronca: Muscle AMP aminohydrolyse. Biochim. biophys. Acta (Amst.)198, 101 (1970).
Randle, P. J.: Regulation of glycolysis and pyruvate oxidation in cardiac muscle. Circulat. Res.38, Suppl. I, 8–15 (1976).
Smirnov, V. N., G. F. Asafov, N. M. Cherpachenko, C. B. Chernousova, V. T. Mozchechkov, V. I. Krivov, A. Ovchinnikov, V. G. Merimsom, V. G. Rozynov, M. N. Chumachenko: Ammonia neutralisation and urea synthesis in cardiac muscle. Circulat. Res.35, Suppl. III, 58–69 (1974).
Watanabe, T.: Significance of ammonia in myocardial metabolism. Jap. Circ. J.32, 1811–1814 (1968).
Author information
Authors and Affiliations
Additional information
With 3 figures and 1 table
Rights and permissions
About this article
Cite this article
Brodan, V., Fabián, J., Anděl, M. et al. Myocardial amino acid metabolism in patients with chronic ischemic heart disease. Basic Res Cardiol 73, 160–170 (1978). https://doi.org/10.1007/BF01906751
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01906751